News | December 07, 2022
Fraunhofer IZI Selects Lonza’s MODA-ES Solution to Digitalize Manufacturing Operations
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
Dr. Mahdavi will lead Ginkgo's commercial efforts in the growing areas of bio-reagents, cell and gene therapies and new biopharmaceutical modalities.
GlobalData’s ‘Pharmaceutical Intelligence Center’ observes that India is still in the nascent stage of developing these potential therapies as currently only four cell/gene therapy molecules are being developed in the country.
Cellutions BioStorage is a comprehensive biomaterial storage and logistics company with a vision to leverage advanced technologies to serve biopharmaceutical companies
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
Under the agreement, Porton Advanced will provide services to accelerate the development, production and registration of breakthrough cell therapies currently being developed by Sinorda Biomedicine
Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction
The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut
Subscribe To Our Newsletter & Stay Updated
